Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer.

MLA

Chan, Phyllis, et al. “Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer.” CPT: Pharmacometrics & Systems Pharmacology, Feb. 2025. EBSCOhost, https://doi.org/10.1002/psp4.13310.

APA

Chan, P., Liu, S. N., Gosselin, N., Sauve, Z., Marchand, M., Lin, A., Herraez-Baranda, L., Zanghi, J., Shearer-Kang, E., Liu, X., Wu, B., & Chanu, P. (2025). Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13310

Chicago

Chan, Phyllis, Stephanie N Liu, Nathalie Gosselin, Zacharie Sauve, Mathilde Marchand, Alyse Lin, Luis Herraez-Baranda, et al. 2025. “Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer.” CPT: Pharmacometrics & Systems Pharmacology, February. doi:10.1002/psp4.13310.